Mariko Nakafuji
Director/Board Member at Idorsia Pharmaceuticals Japan Ltd.
Network origin in Mariko Nakafuji first degree
Entity | Entity type | Industry | |
---|---|---|---|
Idorsia Pharmaceuticals Japan Ltd.
Idorsia Pharmaceuticals Japan Ltd. Pharmaceuticals: MajorHealth Technology Part of Idorsia Ltd., Idorsia Pharmaceuticals Japan Ltd. is a company based in Tokyo, Japan. The Japanese company's description focuses on a nationwide contest aimed at expressing gratitude to medical professionals and raising awareness about the role of medicine and healthcare in society. The contest is designed to encourage elementary school students to think about their future dreams, their own and their family's health, and a society where everyone can live a healthy life both physically and mentally.
9
| Subsidiary | Pharmaceuticals: Major | 9 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Mariko Nakafuji via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
NEC FIELDING LTD | Information Technology Services | Corporate Officer/Principal | |
Sosei R&D Ltd.
Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Sosei R&D Ltd. manufactures pharmaceutical products. It develops and commercializes product opportunities based upon clinical uses for known drugs and templates. The company was founded by Julian Gilbert and Robin Bannister in March, 2000 and is located in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Cranfield University | College/University | Masters Business Admin | |
NXERA PHARMA CO., LTD. | Pharmaceuticals: Major | Compliance Officer Director of Finance/CFO Public Communications Contact Corporate Officer/Principal | |
Mizuho Securities Co., Ltd. (Broker)
Mizuho Securities Co., Ltd. (Broker) Investment Banks/BrokersFinance Mizuho Securities Co., Ltd. (Broker) (Mizuho Securities-Broker) is the brokerage division of Mizuho Securities Co. Ltd., ultimately owned by Mizuho Financial Group, Inc. (TYO: 8411; NYSE: MFG) in Japan. The firm was originally founded in 1917 and is headquartered in Tokyo with a network of offices throughout Japan as well as overseas representation through Mizuho entities or strategic partners (in Great Britain, Switzerland, the US, Hong Kong, Mainland China, South Korea, Singapore and India). Mizuho Securities-Broker provides enhanced equity and fixed income execution services for their clients who includes private individuals in Japan, domestic and foreign institutions, non-financial companies, financial institutions and public corporations in the securities and investment banking fields. | Investment Banks/Brokers | Analyst-Equity | |
Kyoto Prefectural University of Medicine | College/University | Doctorate Degree | |
Jitsubo Co., Ltd.
Jitsubo Co., Ltd. BiotechnologyHealth Technology Jitsubo Co., Ltd. researches, develops, and produces peptides. It operates as a peptide development company that provides solutions to patients using their proprietary technologies for manufacturing and engineering peptides. The firm specializes in peptide synthesis, which enables users to modify amino acid sequence for the creation of physical, chemical, and pharmacological properties. It also engages in development of peptide pharmaceuticals, licensing regarding active ingredient manufacturing technology for peptides, and peptide drug discovery research. The company was founded by Yusuke Kohno and Kazuhiro Chiba in 2000 and is headquartered in Tokyo, Japan. | Biotechnology | Director/Board Member |
Statistics
International
Japan | 5 |
United Kingdom | 3 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Technology Services | 2 |
Finance | 2 |
Operational
Director/Board Member | 11 |
Corporate Officer/Principal | 3 |
Chief Administrative Officer | 1 |
Compliance Officer | 1 |
Analyst-Equity | 1 |
Most connected contacts
- Stock Market
- Insiders
- Mariko Nakafuji
- Company connections